TABLE 1.
Group | No. (%) of subjects who converted to HBs positivity at: |
χ2 | P | |||
---|---|---|---|---|---|---|
T1 | T2 | T8 | T12 | |||
Enrerix-40 | 53 (88.33)a,b | 57 (95.0)a,b,c | 59 (98.33)a,b,c | 58 (96.67)a,b,c | 5.663 | 0.148 |
Engerix-20 | 46 (76.67)a | 48 (80.0)a | 51 (85.0)a,b | 52 (86.67)a,b | 2.578 | 0.461 |
Chinese-20 | 42 (70.0)a | 43 (71.67)a | 39 (65.0) | 38 (63.33) | 1.292 | 0.731 |
Chinese-10 | 25 (41.67) | 22 (36.67) | 39 (65.0) | 33 (55.0) | 11.917 | 0.008 |
χ2 | 33.214 | 53.324 | 28.282 | 36.925 | ||
P | <0.001 | <0.001 | <0.001 | <0.001 |
Versus Chinese-10, P < 0.01.
Versus Chinese-20, P < 0.05.
Versus Engerix-20, P < 0.05.